Clear cell adenocarcinoma

Low Expression of S100P Is Associated With Poor Prognosis in Patients With Clear Cell Adenocarcinoma of the Ovary
Yasushi Umezaki, Masahiro Ito, Masahiro Nakashima, Yumi Mihara, Hirokazu Kurohama, Naoko Yatsunami, Ichiro Yasuhi

International Journal of Gynecologic Cancer Nov 2015, 25 (9) 1582-1586; DOI: 10.1097/IGC.0000000000000544
Maximum Standardized Uptake Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Is a Prognostic Factor in Ovarian Clear Cell Adenocarcinoma
Haruhisa Konishi, Kazuhiro Takehara, Atsumi Kojima, Shinichi Okame, Yasuko Yamamoto, Yuko Shiroyama, Takashi Yokoyama, Takayoshi Nogawa, Yoshifumi Sugawara

International Journal of Gynecologic Cancer Sep 2014, 24 (7) 1190-1194; DOI: 10.1097/IGC.0000000000000180
Alterations of Hypoxia-Induced Factor Signaling Pathway Due to Mammalian Target of Rapamycin (mTOR) Suppression in Ovarian Clear Cell Adenocarcinoma: In Vivo and in Vitro Explorations for Clinical Trial
Takeshi Hirasawa, Masaki Miyazawa, Masanori Yasuda, Masako Shida, Masae Ikeda, Hiroshi Kajiwara, Naruaki Matsui, Mariko Fujita, Toshinari Muramatsu, Mikio Mikami

International Journal of Gynecologic Cancer Sep 2013, 23 (7) 1210-1218; DOI: 10.1097/IGC.0b013e31829d2d51
Clear Cell Adenocarcinoma of the Female Genital Tract: Long-Term Outcome and Fertility Aspects After Brachytherapy Aimed at a Conservative Treatment
Nicolas Magné, Cyrus Chargari, Antonin Levy, Carlos Rodriguez, Véronique De Vos, Alain Gerbaulet, Pierre Duvillard, Philippe Morice, Christine Haie-Meder

International Journal of Gynecologic Cancer Oct 2012, 22 (8) 1378-1382; DOI: 10.1097/IGC.0b013e318264a51d
Vaginal and (Uncommon) Cervical Cancers in the Netherlands, 1989-2003
Maaike A. van der Aa, Th. J. M. Helmerhorst, Sabine Siesling, Sietske Riemersma, Jan Willem Coebergh

International Journal of Gynecologic Cancer May 2010, 20 (4) 638-645; DOI: 10.1111/IGC.0b013e3181a44f4
A combination of chemoirradiation and chemotherapy for treatment of advanced clear cell adenocarcinoma of the cervix
K. K.L. CHAN, P. IP, P. KWONG, K. F. TAM, H. Y.S. NGAN

International Journal of Gynecologic Cancer May 2008, 18 (3) 559-563; DOI: 10.1111/j.1525-1438.2007.01037.x
Relationship Between ABCF2 Expression and Response to Chemotherapy or Prognosis in Clear Cell Adenocarcinoma of the Ovary
Hiroshi Tsuda, Kiyoshi Ito, Nobuo Yaegashi, Akira Hirasawa, Tamotsu Sudo, Tsunekazu Kita, Yoshito Terai, Junzo Kigawa, Toru Sugiyama, Daisuke Aoki

International Journal of Gynecologic Cancer Jun 2010, 20 (5) 794-797; DOI: 10.1111/IGC.0b013e3181a835fc
Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen
N. Suzuki, Y. Tamada, K. Shigirahara, A. Suzuki, N. Susumu, I. Ishida, D. Aoki

International Journal of Gynecologic Cancer Aug 2008, 18 (5) 996-1006; DOI: 10.1111/j.1525-1438.2007.01147.x
Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer
K. Ikeda, K. Sakai, R. Yamamoto, H. Hareyama, N. Tsumura, H. Watari, M. Shimizu, H. Minakami, N. Sakuragi

International Journal of Gynecologic Cancer Oct 2003, 13 (6) 776-784; DOI: 10.1136/ijgc-00009577-200311000-00008
Sperm protein 17 influences the tissue-specific malignancy of clear cell adenocarcinoma in human epithelial ovarian cancer
T. Nakazato, T. Kanuma, T. Tamura, L. S. Faried, H. Aoki, T. Minegishi

International Journal of Gynecologic Cancer Feb 2007, 17 (2) 426-432; DOI: 10.1111/j.1525-1438.2007.00815.x

Main menu

Clear cell adenocarcinoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Clear cell adenocarcinoma

Pages